IMIP - Instituo de Medicina Integral Professor Fernando Figueira
Recife, Pernambuco, 50070-550, Brazil
NCT Number: NCT05004623
This is an early feasibility study to evaluate the device functionality of an open-field handheld wireless fluorecence imaging system for detection of sentinel lymph nodes in women with cervical and uterine cancers who underwent open surgery.
Looking for future studies?
Notify Me18 year–70 year
Female
Interventional
Not applicable
Recife, Pernambuco, 50070-550, Brazil
This study was designed to clinically evaluate the functionality of an prototype of our near-infrared fluorescence device named Easy Light. In brief, this device is an open-field handheld wireless fluorecence imaging system that allows real-time visualization of fluorescent dyes such as indocyanine green (ICG) using smartphones and tablets. The handheld is a rechargeable device responsible for excitation of the operative field with infra-red lighting and for capturing the fluorescence emitted by de fluorescent dye to be visualized via wi-fi in the smartphones and tablets using a pre-installed application software. Following the standards of near-infrared fluorescence for detection of sentinel lymph nodes in gynecological malignancies, the hypothesis was the identification of sentinel lymph nodes after lymphatic mapping by interstitial indocyanine green injection in the cervix was feasible with the use of our device named Easy Light.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Detection of sentinel lymph nodes by indocyanine green (ICG) fluorescent dye technique, using a prototype of the Easy Light device.
Time frame: Intraoperativelly
The ability to detect at least one sentinel lymph node per patient during open surgeries.
Professor Fernando Figueira Integral Medicine Institute
Other
Early Feasibility Study of an Open-Field Handheld Wireless Fluorecence Imaging System for Detection of Sentinel Lymph Nodes in Women With Cervical and Uterine Cancers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02825355
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Copenhagen, Denmark
View Trial DetailsNCT01654458
Adnexal Diseases, Endocrine Gland Neoplasms
New York, United States
View Trial DetailsNCT04351139
Adnexal Diseases, Breast Neoplasm Female
Bron, France
View Trial DetailsNCT02444195
Adnexal Diseases, Endocrine Gland Neoplasms
Ann Arbor, Michigan, United States
View Trial Details